Depo-Medrol Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Methylprednisolone acetate

Indications/Uses

Endocrine, rheumatic & haematologic disorders; collagen, dermatologic, ophth, GI, resp & neoplastic diseases, allergic & edematous states; acute exacerbation of multiple sclerosis; tuberculous meningitis w/ subarachnoid or impending block when used concurrently w/ appropriate anti-TB chemotherapy; trichinosis w/ neurologic or myocardial involvement. As adjunctive therapy for short term intra-synovial administration in acute episode or exacerbation. Intralesional administration in keloids, localized hypertrophic, infiltrated & inflammatory lesions.

Click to view Depo-Medrol detailed prescribing information

Dosage/Direction for Use

RA & OA Large joint: 20-80 mg. Medium joint: 10-40 mg. Small joint: 4-10 mg. By IA administration for local effect & IM for systemic effect.

Click to view Depo-Medrol detailed prescribing information

Overdosage

View Depo-Medrol overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity. Systemic fungal infection. Do not inj IV, epidural or intrathecally. Use w/ live or live attenuated vaccines.

Click to view Depo-Medrol detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Depo-Medrol detailed prescribing information

Special Precautions

Unusual stress, intercurrent infection; immunisation (defer); active or latent TB; ocular herpes simplex; renal insufficiency, HTN; osteoporosis; myasthenia gravis. Non-specific ulcerative colitis. Not for intrathecal administration. Pregnancy.

Click to view Depo-Medrol detailed prescribing information

Use In Pregnancy & Lactation

Click to view Depo-Medrol detailed prescribing information

Adverse Reactions

Local atrophy, pigmentation changes, post-inj flare, sterile abscess, Charcot-like syndrome; Na & fluid retention; impaired wound healing, thin fragile skin; decreased carbohydrate tolerance; muscle weakness, myopathy, aseptic necrosis, tendon rupture; cataract, increased IOP & ICP; growth retardation; psychic derangements.

Click to view Depo-Medrol detailed prescribing information

Drug Interactions

Mutual inhibition of metabolism of methylprednisolone w/ cyclosporine. Increased methylprednisolone clearance w/ phenytoin, phenobarb, rifampicin. Inhibit metabolism & decrease clearance of methylprednisolone w/ troleandomycin & ketoconazole. Methylprednisolone may increase the clearnace of chronic high-dose aspirin & decrease salicylate levels. Corticosteroids may enhance as well as diminish effect of anticoagulant.

Click to view Depo-Medrol detailed prescribing information

Storage

View Depo-Medrol storage conditions for details to ensure optimal shelf-life.

Description

View Depo-Medrol description for details of the chemical structure and excipients (inactive components).

Action

View Depo-Medrol mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Corticosteroid Hormones

ATC Classification

H02AB04 - methylprednisolone ; Belongs to the class of glucocorticoids. Used in systemic corticosteroid preparations.

Regulatory Classification

Presentation/Packing

Form

Depo-Medrol powd for inj 40 mg/mL

Packing/Price

(vial) 1 mL x 1's (Rp123,054/boks)

Depo-Medrol

methylprednisolone

Manufacturer:

Pfizer